Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial - Concepedia

Concepedia

Publication | Closed Access

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

432

Citations

17

References

2016

Year

Séverine Vermeire, Stefan Schreiber, Robert Petryka, Tanja Kuehbacher, Xavier Hébuterne, Xavier Roblin, Maria Kłopocka, Adrian Goldiș, Maria Wiśniewska‐Jarosińska, Andrey Baranovsky,

Fitzroy StudyGastroenterologyClinical GastroenterologyUlcerative ColitisPhase 2MedicineClinical Remission

References

	Year	Citations

Page 1